scispace - formally typeset
C

Catherine Ricciardi

Researcher at Massachusetts Institute of Technology

Publications -  11
Citations -  895

Catherine Ricciardi is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Vitamin D and neurology & Binocular rivalry. The author has an hindex of 6, co-authored 11 publications receiving 809 citations. Previous affiliations of Catherine Ricciardi include McGovern Institute for Brain Research.

Papers
More filters
Journal ArticleDOI

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

TL;DR: A mass spectrometry‐based strategy to simultaneously measure 191 metabolites following glucose ingestion laid the groundwork for using metabolic profiling to define an individual's ‘insulin response profile’, which could have value in predicting diabetes, its complications, and in guiding therapy.
Journal ArticleDOI

Vitamin D–binding protein modifies the vitamin D–bone mineral density relationship

TL;DR: The findings have important implications for vitamin D supplementation in vitamin D–deficient states and future studies should continue to explore the relationship between free and bioavailable 25(OH)D and health outcomes.
Journal ArticleDOI

Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults

TL;DR: While circulating levels of cathelicidin have been most tightly linked to sepsis and mortality, little is known about the association of vitamin D status and plasma cathe Licidin in healthy individuals, or of the ability of vitaminD supplementation to alter these levels.

Iconographies supplémentaires de l'article : Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults

TL;DR: In this article, the relationship between cathelicidin, vitamin D status, and vitamin D supplementation was investigated using multivariate linear spline regression (with an inflection point at 32 ng/ml) and multiple linear regression was used to confirm this approach.
Journal ArticleDOI

GABAergic Inhibition Gates Perceptual Awareness During Binocular Rivalry

TL;DR: It is found that drugs that modulate the two dominant GABA receptor types in the brain, GABAA (clobazam) and GABAB (arbaclofen), increase perceptual suppression during rivalry relative to a placebo, the first causal link between GABAergic inhibition and binocular rivalry in humans.